Search News

Corporate Industry Technology Medical Updates

Extra-VAD

Corporate
magAssist's extracorporeal ventricular assist device (Extra-VAD) was presented in the 2021 Suzhou New District Science and Technology Innovation Exhibition 2021-07-12
Medical Updates
Big country Great Medic｜Nianguo Dong's team, pioneer of heart transplantation in China 2021-06-09
Medical Updates
The Surgical Team of Guangdong Provincial People's Hospital Completed the Preclinical Training on Extracorporeal Ventricular Assist System 2020-12-21
Industry
Dr. Po-Lin Hsu and her "Heart" of magAssist 2020-05-10
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023 2023-08-21
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum 2023-01-16
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,